The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
In this webinar, we discuss the clinical contract evaluation process, including government requirements, expectations, and improving contract…
On-Demand Educational Webinars
A panel of health care industry leaders shares their insights and experiences in creating a best-practice supply chain that supports the intersection…
Book
This manual is divided into four distinct units, which include: Materials Management Organization and Administration, Materials Management Functional…
Webcast
Lana Makhanik and Peter Fiorentino discuss discus why Beth Israel Deaconess Medical Center is breathing easier after they overhauled their inventor
On-Demand Educational Webinars
New risk sharing models align the economics of an agreement to product or service performance and outcomes. In this webinar, we discuss this…
On-Demand Educational Webinars
This session is a comprehensive approach to understanding Lean Management System concepts, processes, tools, and their application to improving…